Skip to main content
logo
Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
4.700
-0.080 (-1.67%)
Oct 23, 2026, 3:04 PM CST

SHE:002581 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
256.94274.81360.41429.79357.08402.71
Revenue Growth
-0.31%-23.75%-16.14%20.36%-11.33%45.47%
Gross Profit
66.6121.89272.74336.5280.44316.88
Operating Income
-190.56-189.51-90.86-155.81-175.57-203.95
Net Income
-184.11-116.28-137.31-332.46-14.68271
Earnings Per Share
-0.28-0.18-0.21-0.50-0.020.41
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Biopharmaceutical
188.68360.41
Traditional Chinese Medicine Decoction Pieces Processing
83.07-
Pharmaceutical Distribution
2.99-
Unallocated Other
0.07-
Total
274.81360.41

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
208.57220.27506.4151.91183.8187.8
Total Debt
61.9361.432.9414.55165.35177.16
Net Cash (Debt)
146.64158.84503.47137.3618.4510.64
Net Cash Growth
-42.37%-68.45%266.52%644.38%73.50%-90.91%
Net Cash Per Share
0.220.240.760.210.030.02

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-116.8-253.73-6.55-36.51-54.49-46.02
Capital Expenditures
-122.01-179.7-9.01-4.32-31.46-60.85
Free Cash Flow
-238.81-433.43-15.56-40.82-85.95-106.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
25.92%44.36%75.67%78.30%78.54%78.69%
Operating Margin
-74.17%-68.96%-25.21%-36.25%-49.17%-50.64%
Pretax Margin
-88.27%-63.87%-40.56%-72.88%3.56%69.18%
Profit Margin
-71.65%-42.31%-38.10%-77.35%-4.11%67.29%
FCF Margin
-92.94%-157.72%-4.32%-9.50%-24.07%-26.53%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
-----51.98
PS Ratio
12.0718.0119.4822.4129.1034.98